Author

c. orhan

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1 Organism:rat· 1

Frequent Co-Authors

F. Uckun· 2 shared I. Ozercan· 2 shared K. Sahin· 2 shared E. Sahin· 1 shared J. Powell· 1 shared M. Gitterle· 1 shared M. Volk· 1 shared

Activity by Year

2020-2021 · peak 1/yr

Co-Author Collaboration Network

7 top collaborators · 18 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersPharmacology & Toxicology

F. Uckun

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Non-clinical safety profile and pharmacodynamics of two formulations of the anti-sepsis drug candidate Rejuveinix

F. Uckun, c. orhan, J. Powell, E. Sahin, I. Ozercan, M. Volk, K. Sahin

This study shows two Rejuveinix formulations have a favorable safety profile in rats and similarly increase antioxidant levels in tissues, indicating bioequivalence.

bioRxiv · Jan 3, 2021Pharmacology & Toxicology

Rejuveinix Reverses Severe Inflammatory Lung Damage in a Mouse Model of Fatal Sepsis

F. Uckun, I. Ozercan, C. Orhan, M. Gitterle, K. Sahin

This study shows that Rejuveinix reduces severe inflammatory lung damage and improves survival in a mouse model of sepsis at a low dose.

bioRxiv · Dec 31, 2020 · PreprintPharmacology & Toxicology